icon-folder.gif   Conference Reports for NATAP  
 
  16th International Workshop
on Clinical Pharmacology of HIV
and Hepatitis Therapy
May 26-28, 2015
Washington, DC
Back grey_arrow_rt.gif
 
 
 
Effect of Ketoconazole on the Pharmacokinetics of Doravirine (MK-1439), a Novel Non-Nucleoside Reverse Transcriptase Inhibitor for the Treatment of HIV-1 Infection
 
 
  Reported by Jules Levin
16th International Workshop on Clinical Pharmacology of HIV
& Hepatitis Therapy (IWCPHIVHT) - May 26-28, 2015 Washington, DC, USA
 
Matt S Anderson,1 Chris Chung,1 Ernestina Tetteh,1 Ka Lai Yee,1 Ying Guo,1 Li Fan,1 Scott Rasmussen,2 John A Wagner,1 Joan R Butterton1 1Merck & Co., Inc., Kenilworth, NJ, USA; 2Celerion, Lincoln, NE, USA

Pharm1.gif

Pharm2.gif

Pharm3.gif

Pharm4.gif

Pharm5.gif

Pharm6.gif

Pharm7.gif

Pharm8.gif